Market cap
$1,820 Mln
Revenue (TTM)
$331 Mln
P/E Ratio
--
P/B Ratio
3.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -0.59 | 17.67 | 26.73 | -23.33 | 54.48 |
| EBIT | 31.88 | 38.47 | -207.38 | -146.68 | 9.33 |
| Net Profit | 43.83 | 53.05 | -311.94 | -151.10 | 9.21 |
| EPS | 45.82 | 73.61 | -420.34 | -155.40 | 10.35 |
| Book Value | -- | -- | -16.44 | 29.89 | 108.62 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-24 | Dec-23 |
| EBIT-Margin
| 18.75 | -8.85 | -10.25 | 13.58 | 1.03 |
| Net Margin
| 40.02 | -29.17 | -13.13 | -- | -- |
| Return on equity
| 25.47 | -18.73 | -8.15 | 4.48 | -1.06 |
| Return on Capital
| 15.62 | 7.43 | -- | 3.16 | -0.74 |
| Return on Assets
| 10.35 | 3.66 | -3.97 | 2.75 | -0.64 |
| Debt to Equity (x)
| -- | -- | 0.41 | 0.43 | 0.41 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
--
|
3.16
|
-0.74
|
44.46
|
20.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-8.15
Higher than Peers by 32.25
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
-8.15
|
4.48
|
-1.06
|
72.98
|
54.59
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-3.97
Higher than Peers by 27.01
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
-3.97
|
2.75
|
-0.64
|
28.95
|
11.02
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
EBIT Margin
-10.25
Higher than Peers by 73.37
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
-10.25
|
13.58
|
1.03
|
41.65
|
20.18
|
|
Peer Median
|
-83.62
|
--
|
--
|
--
|
--
|
Net Margin
-13.13
Higher than Peers by 79.54
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
-13.13
|
9.85
|
-2.75
|
40.02
|
19.88
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Higher than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
26.73
Lower than Peers by 27.23
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
26.73
|
0.19
|
-0.68
|
0.64
|
8.44
|
|
Peer Median
|
53.95
|
--
|
--
|
--
|
--
|
EBIT Growth
-207.38
Lower than Peers by 206.58
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
-207.38
|
1,475.27
|
-99.21
|
239.39
|
257.89
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
-311.94
Lower than Peers by 304.64
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
-311.94
|
527.44
|
-102.18
|
282.15
|
201.96
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
EPS Growth
-420.34
Lower than Peers by 434.99
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
-420.34
|
4.72
|
-1.02
|
2.15
|
1.90
|
|
Peer Median
|
14.65
|
--
|
--
|
--
|
--
|
Book Value Growth
-11.08
Lower than Peers by 0.90
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
-11.08
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.18
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.41
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
0.41
|
0.43
|
0.41
|
0.44
|
1.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.08
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
0.08
|
0.01
|
0.01
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
7.62
Higher than Peers by 1.81
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
7.62
|
10.80
|
13.81
|
6.11
|
1.75
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
6.94
Higher than Peers by 1.24
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
6.94
|
9.91
|
12.96
|
5.71
|
1.64
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-5.33
Lower than Peers by 3.24
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
-5.33
|
5.54
|
0.35
|
44.72
|
7.94
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
22.18
Higher than Peers by 3.04
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
22.18
|
16.92
|
19.17
|
20.41
|
30.00
|
|
Peer Median
|
19.14
|
--
|
--
|
--
|
--
|
Asset Turnover
0.30
Higher than Peers by 0.24
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
0.30
|
0.28
|
0.23
|
0.71
|
0.63
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
--
|
60.23
|
150.99
|
70.59
|
64.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
--
|
455.57
|
410.40
|
84.14
|
131.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
--
|
52.84
|
30.78
|
4.05
|
6.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
--
|
462.96
|
530.61
|
150.68
|
189.52
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
--
|
71.55
|
-291.63
|
5.51
|
22.92
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
3.30
Lower than Peers by 1.88
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
3.30
|
3.27
|
3.00
|
2.78
|
7.91
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
30.92
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
30.92
|
32.71
|
142.54
|
4.06
|
15.35
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
1,820
Higher than Peers by 1,674
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Dynavax Technologies (DVAX)
|
1,820
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|